Risk factors

High debt under the Wells Fargo Credit Agreement and DPLTA obligations limit financial flexibility and operating activities. Material weaknesses in internal control over financial reporting required restating previously issued financial statements. Customer concentration among major Service Providers heavily impacts quarterly revenue and inventory management.

Heavy reliance on Boeing 737 MAX deliveries and quality oversight after recent safety incidents.

Amphastar faces heavy concentration risks from top customers and critical reliance on single-source suppliers and key executives. Significant debt from the BAQSIMI acquisition and extensive regulatory oversight shape operational risks. R&D spending and ongoing product development are central to future revenue streams.

Annexon depends heavily on financing its lead clinical programs ANX005 for GBS and ANX007 for dry AMD. The company faces high regulatory hurdles, international trial execution risks, and lacks internal commercial infrastructure.

ArcBest faces critical risks related to labor negotiations for ABF Freight and multiemployer pension obligations. Equipment availability, rising OEM costs, and fuel price volatility heavily impact operations. Dependence on IT systems and third-party transportation networks introduces significant cybersecurity and disruption risks.

Array Technologies faces concentrated risks in global solar demand, customer and supplier reliance, commodity price volatility, and heavy debt obligations.

ArriVent BioPharma is a clinical-stage company heavily reliant on firmonertinib and its exclusive license from Allist. The business faces significant capital requirements, clinical trial risks, and regulatory hurdles including potential accelerated approval paths. Operations are concentrated around 52 full-time employees relying on third-party manufacturers and clinical sites.

Banc of California faces significant risks from credit exposure in residential and real estate loan portfolios. Integration of mergers and balance sheet repositioning strategy drive material operational and financial uncertainties. Cyber threats and dependence on third-party payment platforms like Deepstack present major operational challenges. Extensive regulatory oversight and interest rate volatility significantly impact capital requirements and net interest income.

Financial success depends heavily on the Atlanta Braves achieving on-field success and player retention.

The risk profile is dominated by the proposed merger with Brookline, including integration challenges, costs, and dilution.

Biodesix faces continuous operating losses with an accumulated deficit of $462.5 million as of December 31, 2024. Revenue depends heavily on Medicare reimbursement and biopharmaceutical collaborations. The company relies on single-source suppliers like Bio-Rad for its GeneStrat test.

No prior year risks on file for BGC Group, Inc., so all 40 risks are presented for the first time.